Barclays Starts Eastman Chemical (EMN) at Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EMN Hot Sheet
Price: $67.61 --0%
Rating Summary:
13 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Rating Summary:
13 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Join SI Premium – FREE
Barclays analyst Aleksey Yefremov initiates coverage on Eastman Chemical (NYSE: EMN) with a Equalweight rating and a price target of $725.00.
For an analyst ratings summary and ratings history on Eastman Chemical click here. For more ratings news on Eastman Chemical click here.
Shares of Eastman Chemical closed at $62.69 yesterday.
You May Also Be Interested In
- Eastman Chemical (EMN) PT Raised to $70 at RBC Capital
- UBS Starts SenseTime Group Inc (20:HK) at Neutral
- BMO Capital Starts Astera Labs (ALAB) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
